Savant Capital, LLC Pfizer Inc Transaction History

Savant Capital, LLC

$11.7 Billion
Q3 2024

A detailed history of Savant Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Savant Capital, LLC holds 252,490 shares of PFE stock, worth $6.75 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

252,490

Previous 218,485 15.56%

Holding current value

$6.75 Million

Previous $6.11 Million 19.53%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $941,938 - $1.07 Million	34,005 Added 15.56%	252,490 $7.31 Million
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $349,876 - $409,989	-13,851 Reduced 5.96%	218,485 $6.11 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $489,709 - $562,342	18,915 Added 8.86%	232,336 $6.45 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $211,052 - $274,133	-8,077 Reduced 3.65%	213,421 $6.14 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $79,872 - $93,362	2,489 Added 1.14%	221,498 $7.35 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $2.75 Million - $3.19 Million	76,231 Added 53.39%	219,009 $8.03 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $1.5 Million - $1.95 Million	-38,068 Reduced 21.05%	142,778 $5.83 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $166,666 - $217,564	3,992 Added 2.26%	180,846 $9.27 Million
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $3.37 Million - $4.39 Million	80,618 Added 83.77%	176,854 $9.07 Million
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $75,223 - $91,828	1,719 Added 1.82%	96,236 $4.21 Million
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $159,644 - $189,288	3,431 Added 3.77%	94,517 $4.96 Million
Q1 2022 May 05, 2022	BUY	$45.75 - $56.69 $37,926 - $46,996	829 Added 0.92%	91,086 $4.72 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $218,541 - $323,951	5,289 Added 6.22%	90,257 $5.33 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $402,940 - $517,611	10,266 Added 13.74%	84,968 $3.65 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $286,489 - $324,545	7,978 Added 11.96%	74,702 $2.93 Million
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $7,267 - $8,196	217 Added 0.33%	66,724 $2.42 Million
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $41,000 - $52,136	-1,225 Reduced 1.81%	66,507 $2.45 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $21,526 - $25,255	-678 Reduced 0.99%	67,732 $2.49 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $129,154 - $156,683	-4,288 Reduced 5.9%	68,410 $2.24 Million
Q1 2020 Apr 30, 2020	BUY	$27.03 - $38.62 $324,846 - $464,135	12,018 Added 19.81%	72,698 $2.37 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $30,846 - $35,006	937 Added 1.57%	60,680 $2.38 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $45,258 - $58,687	1,393 Added 2.39%	59,743 $2.15 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $4,363 - $4,899	118 Added 0.2%	58,350 $2.53 Million
Q1 2019 May 02, 2019	BUY	$37.5 - $41.2 $17,212 - $18,910	459 Added 0.79%	58,232 $2.47 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $34,276 - $39,079	-891 Reduced 1.52%	57,773 $2.52 Million
Q3 2018 Oct 23, 2018	BUY	$34.47 - $41.81 $5,239 - $6,355	152 Added 0.26%	58,664 $2.59 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $43,896 - $46,797	1,331 Added 2.33%	58,512 $2.12 Million
Q1 2018 Apr 27, 2018	BUY	$31.91 - $37.02 $71,478 - $82,924	2,240 Added 4.08%	57,181 $2.03 Million
Q4 2017 Jan 31, 2018	BUY	$33.26 - $35.29 $76,498 - $81,167	2,300 Added 4.37%	54,941 $1.99 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $1.63 Million - $1.8 Million	52,641	52,641 $1.88 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Account

Savant Capital, LLC Pfizer Inc Transaction History